New hope for young cancer patients: drug aims to speed platelet recovery after transplant
NCT ID NCT06818916
First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 20 times
Summary
This study tests whether the drug hetrombopag can help children with neuroblastoma recover their platelets more quickly after a stem cell transplant. About 30 children will take the drug daily for up to 6 weeks. The main goal is to see if it reduces the need for platelet transfusions and speeds up platelet recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Stem Cell Transplantation, Beijing Children's Hospital, Capital Medical University
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.